We are live on ! Find out more
MP

Mangrove Partners Portfolio holdings

AUM $1.24B
1-Year Est. Return 41.74%
This Fund
S&P 500
This Quarter Est. Return
+11.15%
1 Year Est. Return
+41.74%
3 Year Est. Return
+169.22%
5 Year Est. Return
+150.23%
10 Year Est. Return
+417.9%
AUM
$1.23B
AUM Growth
-$126M
Cap. Flow
-$64.2M
Cap. Flow %
-5.23%
Top 10 Hldgs %
47.46%
Holding
461
New
283
Increased
16
Reduced
28
Closed
90

Sector Composition

Rank Sector Weight
1 Healthcare 24.64%
2 Financials 19.07%
3 Materials 14.06%
4 Technology 13.25%
5 Consumer Discretionary 6.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FG icon
401
F&G Annuities & Life
FG
$3.82B
-15,170
Closed -$474K
FIZZ icon
402
National Beverage
FIZZ
$2.97B
-18,585
Closed -$686K
GD icon
403
General Dynamics
GD
$104B
-2,653
Closed -$905K
HTH icon
404
Hilltop Holdings
HTH
$2.25B
-29,538
Closed -$987K
IBIT icon
405
iShares Bitcoin Trust
IBIT
$46.8B
-290,122
Closed -$18.9M
BRSL
406
Brightstar Lottery PLC
BRSL
$1.83B
-53,763
Closed -$927K
IT icon
407
Gartner
IT
$10.1B
-2,468
Closed -$649K
JNJ icon
408
Johnson & Johnson
JNJ
$622B
-4,712
Closed -$874K
LAUR icon
409
Laureate Education
LAUR
$5.26B
-1,181,479
Closed -$37.3M
LLY icon
410
Eli Lilly
LLY
$1.02T
-2,335
Closed -$1.78M
LNN icon
411
Lindsay Corp
LNN
$1.13B
-6,010
Closed -$845K
LNW
412
DELISTED
Light & Wonder
LNW
-15,483
Closed -$1.3M
LRMR icon
413
Larimar Therapeutics
LRMR
$394M
-442,236
Closed -$1.43M
MOH icon
414
Molina Healthcare
MOH
$10.1B
-4,252
Closed -$814K
MREO
415
Mereo BioPharma
MREO
$52.3M
-7,790,580
Closed -$16M
NEM icon
416
Newmont
NEM
$98.8B
-12,004
Closed -$1.01M
NGD
417
DELISTED
New Gold Inc
NGD
-159,742
Closed -$1.15M
NVDA icon
418
NVIDIA
NVDA
$4.82T
-4,612
Closed -$861K
OMAB icon
419
Grupo Aeroportuario Centro Norte
OMAB
$5.16B
-7,786
Closed -$809K
ORCL icon
420
Oracle
ORCL
$371B
-3,352
Closed -$943K
PCAR icon
421
PACCAR
PCAR
$70B
-8,473
Closed -$833K
PFE icon
422
Pfizer
PFE
$143B
-33,105
Closed -$844K
PLTR icon
423
Palantir
PLTR
$293B
-4,697
Closed -$857K
PTGX icon
424
Protagonist Therapeutics
PTGX
$8.72B
-478,413
Closed -$31.8M
QFIN icon
425
Qfin Holdings
QFIN
$1.69B
-26,049
Closed -$750K

Similar funds

Mangrove Partners's Q4 2025 Portfolio in Review

As of Q4 2025, Mangrove Partners held 461 positions worth $1.23B, down 9.3% from $1.35B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Mangrove Partners withdrew a net $64.2M in Q4 2025, closing 90 positions and reducing 28 holdings. Its most notable exit was Somnigroup International, an estimated $48.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 20% a quarter earlier, followed by Financials and Materials.

Against the trend, Mangrove Partners opened a new position in Becton Dickinson worth $48M.

  • Mangrove Partners's largest Q4 2025 buy was Becton Dickinson: 247,317 shares worth $48M.
  • Mangrove Partners added most to REX American Resources in Q4 2025, an estimated $15.9M increase.
  • Mangrove Partners's biggest Q4 2025 reduction was Enova International, cutting an estimated $27.4M.
  • Mangrove Partners fully exited Somnigroup International in Q4 2025, selling an estimated $48.6M.
  • Mangrove Partners's ten largest holdings make up 47% of its $1.23B portfolio in Q4 2025.
  • Mangrove Partners opened 283 new positions and closed 90 in Q4 2025.
  • Mangrove Partners's portfolio value fell 9.3% quarter-over-quarter to $1.23B.

Based on Mangrove Partners's 13F filing for Q4 2025, filed 17 Feb 2026.